Oncoinvent (private company)

See something wrong or missing? Let us know
Offices:Oslo
Business model:B2B

Oncoinvent AS is a pharma company based in Oslo, Norway designing better cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.

Investors: we tracked 13 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 58.79M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Oncoinvent

Name Criteria
Germany Atai Life Sciences
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Norway Mentis Cura
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Netherlands Leyden Labs
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France Xenothera
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Sweden Monocl
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
United Kingdom Sano Genetics
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Spain Veritas Intercontinental
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Top